AARP's venture capital arm, primarily through the AARP Innovation Fund and AgeTech Collaborative, focuses on investing in "AgeTech" or "longevity tech" companies. Their strategy is to support products and services that improve the lives of the 50+ population, with an emphasis on areas such as health care access, aging in place, preventive health, and financial well-being.
43% of their portfolio is in Healthcare. Their most common stage is seed (57% of deals). Average disclosed round size is $5.9M (across 5 rounds with reported amounts).
Portfolio
7
Fund Size
$40M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
Top Co-Investors
StartUp Health2 shared
Factory2 shared
M12, Microsoft's Venture Fund2 shared
Quake Capital2 shared
Mentors fund1 shared
Two Lanterns1 shared
Scrum Ventures1 shared
Reflect Ventures1 shared
GoAhead Ventures1 shared
Pillar1 shared
OCA Ventures1 shared
Amazon Alexa Fund1 shared
Connecticut Innovations1 shared
Blockchange Ventures1 shared
Last updated: 13 March 2026